Atlas Trials

Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application

Clinical trial NCT06233357 · COMPLETED

Trial details

NCT number
NCT06233357
Sponsor
University of Ulm
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19Outcome, FatalTocilizumabInterleukin 6Critically Ill
Start date
2021-08-01
Primary completion
2022-04-28
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.